Role of Guda Haritaki in Gout

Efficacy of Guda Haritaki in the disintegration of pathogenesis of Vatarakta (Gout)- A single arm clinical trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052761

Enrollment

Registered

2023-05-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed patients of Vatarakta (Gout) with Hyperuricaemia and presenting with the classical sign and symptoms of Vatarakta (Gout) Subjects consenting to participate in the study

Exclusion criteria

Exclusion criteria: Subjects suffering from other systemic illnesses Subjects suffering from autoimmune diseases of the joints Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
This study is expected to be helpful in the management of Vatarakta (Gout) Timepoint: 45 days	—

Secondary

Measure	Time frame
This study will provide cost effective, safe drug with lesser side effectsTimepoint: 12 months	—

Countries

India

Contacts

Public ContactDr Aditaya Nath Tewari

Chaudhary Brahm Prakash Ayurved Charak Sansthan, Khera Dabar Najafgarh NEW Delhi 110073

dr.aditaya@gmail.com

Outcome results